Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
We continue to present final videos from this highly anticipated annual event, the 2020 Targeted Therapies Patient Forum. This year's live-online...
GRACE is excited to bring you a new series on current updates in Melanoma Treatment. Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow...
GRACE is excited to bring you a new series on current updates in Melanoma Treatment. Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow...
GRACE is excited to bring you a new series on current updates in Melanoma Treatment Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow...
We are excited to be able to present final videos from this highly anticipated annual event, the 2020 Targeted Therapies Patient Forum. This year's...
Advance directives are a powerful way to take control of healthcare choices. These documents allow you to outline preferences for medical care and specify end-of-life wishes. These documents can also be a way to appoint loved ones who you would like to help with these decisions, such as a healthcare proxy (someone to make decisions on your behalf, if you cannot). As cancer treatments can involve aggressive treatments and/or complex medical management, having advance directives ensures that your desires regarding treatment options and end-of-life care are clearly communicated.
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial. We want to hear from you!
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial. We want to hear from you!
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial. We want to hear from you!
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial. We want to hear from you!
Hello OutThere! This is Janine, GRACE's Community Outreach Team member. I've been a part of the Grace community since 2009, just before my husband was...
i had nodules for years they had been watching them , then on jan27 went for my yearly cat scan thy said one of my nodules had grown and a new one appeared , protocal was to do another in 3 months which they did , i just got the call one had grew more , i have to have a pet scan then she wants a pulmanary function test done , i am so scared this was over the phone so many questions and no answers.. last i knew it was 8mm but i do not know what the last result was, am i gonna die or do i have a chance, i am so scared,,,
I'm 57 and recently diagnosed with nsclc with negative EGFR, ROS, ALK but with PD-L1 > 80. The tumor in my lung is in the right lower lobe about 2-2.5 cm in size, and only one bone met about 3cm in my right ala.
My 57-year old brother was finally diagnosed Friday with Invasive Mucinous Adenocarcinoma after being misdiagnosed with pneumonia since June 2020. It started with consolidation in the lower right lobe, but now his right lung is fully compromised and it has spread to his left lung. So he's had the cancer untreated now for almost a year and it's so widespread. Are we too late? The thoracic surgeon who did the wedge resection removed three tumors for testing and says he won't refer to a cancer hospital until he gets the results in a few weeks.
In this continued time of social distancing and limiting clinic exposure, the doctors sat down in their respective homes to discuss some of the questions we all hear regarding these unprecedented times, and how they effect primarily cancer patients.
In this continued time of social distancing and limiting clinic exposure, the doctors sat down in their respective homes to discuss some of the questions we all hear regarding these unprecedented times, and how they effect primarily cancer patients.
Dear Cancer Grace Team,
Thank you for the amazing work you do to support families like us.
My mom (76 year old) was recently admitted to hospital with massive pleural efussion in her right lung.
They performed Thoracoscopy + Talc Pleurodesis and upon performing pleural biopsy they confirmed today it as Adenocarcinoma (IHC markers - TTF1 - nuclear positive and P40 - negative).
Immediately after biopsy (before report came out), Doctors recommended to start Gefitinib or Osimertinib depending on our finances.
This year's live-online presentations and discussions were launched by our Event Chair, Luis E. Raez, MD FACP FCCP, Member of the GRACE Board of Directors, President of the Florida Society of Clinical Oncology (FLASCO), and Chief Scientific Officer & Medical Director at Memorial Cancer Institute.
This year's live-online presentations and discussions were launched by our Event Chair, Luis E. Raez, MD FACP FCCP, Member of the GRACE Board of Directors, President of the Florida Society of Clinical Oncology (FLASCO), and Chief Scientific Officer & Medical Director at Memorial Cancer Institute.
Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow, MD Chief of Melanoma Service at Memorial Sloan Kettering, and Sanjiv Agarwala, MD, Professor of Medical Oncology and Hematology at Temple University School of Medicine in Easton, PA joined GRACE to discuss current updates in treatment for Melanoma.
A huge thank you to Merck for sponsoring this program.
Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow, MD Chief of Melanoma Service at Memorial Sloan Kettering, and Sanjiv Agarwala, MD, Professor of Medical Oncology and Hematology at Temple University School of Medicine in Easton, PA joined GRACE to discuss current updates in treatment for Melanoma.
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.